AMR and COVID-19

How can Europe incentivise R&D to protect our future?

Thursday, 1 October 2020 | 16:30-18:00 | Room 1

Organised by MSD

Antimicrobial resistance (AMR) is one of the greatest challenges of our age and yet, despite the global discussion around antimicrobial innovation, there has been limited action to address the fundamental economic challenges that have de-incentivised  antimicrobial R&D. Policymakers need to move beyond the traditional approaches to finally “dance with the elephant” – that is, to put in place the necessary market-based reforms that will drive sustainable private investment in antimicrobial R&D.

The COVID-19 pandemic is a wake-up call for health system preparedness and innovation against infectious diseases. It has made clear the huge human and economic costs when we do not have the treatments, vaccines, and diagnostics we need. Further, COVID-19 has highlighted the fundamental role antibiotics play in the treatment of secondary bacterial infections.

Unlike COVID-19, AMR is a predictable and preventable crisis. This timely session will ask:

  • What market reforms are necessary to address the economic barriers to sustainable investment in antimicrobial R&D? How can these support access and appropriate use?
  • What is the role of non-governmental and multi-sector collaborations in driving policy action?
  • What steps should the EU take, e.g. via the forthcoming Pharmaceutical Strategy and the new EU health programme, to enable sustainable investment into the antimicrobial pipeline?

Session Recording

Speakers & panellists

  • Cristian-Silviu Buşoi, MEP, European Parliament
  • Jeremy Knox, Policy and Advocacy Lead AMR, Wellcome Trust
  • Jenelle Krishnamoorthy, Vice President of Policy, Communications, and Population Health, MSD
  • John Ryan, Director of the Public Health, Country Knowledge & Crisis Management Directorate, European Commission Directorate-General for Health and Food Safety
  • Christine Årdal, Senior Adviser, Antimicrobial Resistance Centre, Norwegian Institute of Public Health

Moderated by


EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office